Efficacy and safety of ixekizumab in psoriatic arthritis: a retrospective, single-centre, observational study in a real-life clinical setting

被引:0
|
作者
Manfreda, V. [1 ]
Chimenti, M. [2 ]
Canofari, C. [2 ]
Esposito, M. [1 ,3 ]
Perricone, R. [2 ]
Bianchi, L. [1 ]
Giunta, A. [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Dermatol, Via Montpellier 1, Rome, Italy
[2] Univ Roma Tor Vergata, Dept Rheumatol Allergol & Clin Immunol, Rome, Italy
[3] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Dept Dermatol, Laquila, Italy
关键词
INADEQUATE RESPONSE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:581 / 582
页数:2
相关论文
共 50 条
  • [31] ENTHESITIS AND CLINICAL RESPONSE IN PSORIATIC ARTHRITIS: REAL-LIFE DATA
    Ganhao, S.
    Garcia, S.
    Fernandes, B. M.
    Rato, M.
    Pinheiro, F.
    Mariz, E.
    Bernardes, M.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1157 - 1157
  • [32] Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: A single-centre observational study
    Boussofara, Amine
    Godin, Matthieu
    Canville, Alexandre
    Baala, Brahim
    Berland, Jacques
    Koning, Rene
    Landolff, Quentin
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2024, 103 (04) : 650 - 659
  • [33] Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients
    Atas, N.
    Eroglu, G. A.
    Sodan, H. N.
    Ozturk, B. O.
    Babaoglu, H.
    Satis, H.
    Karadeniz, H.
    Guler, A. A.
    Salman, R. B.
    Goker, B.
    Ozturk, M. A.
    Haznedaroglu, S.
    Tufan, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : S30 - S36
  • [34] EFFICACY OF USTEKINUMAB IN A COHORT OF PATIENTS AFFECTED BY PSORIATIC ARTHRITIS IN REAL-LIFE
    Notario Ferreira, I.
    Ferrer Gonzalez, M.
    Morales Garrido, P.
    Anon Onate, I.
    Perez Albaladejo, L.
    Caro Hernandez, C.
    Gonzalez Utrilla, A.
    Raya Alvarez, E.
    Caliz Caliz, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1321 - 1321
  • [35] Efficacy of adalimumab in psoriatic arthritis (PsA) in real-life clinical practice: Preliminary results of STEREO
    Van den Bosch, Filip
    Manger, Bernhard
    Frank, Martina
    Kupper, Hartmut
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB184 - AB184
  • [36] Paediatric Integrase Inhibitor Use in a Real-Life Setting: A Single-Centre Cohort Experience 2009–2018
    Yara-Natalie Abo
    Erika Refsum
    Nicola Mackie
    Hermione Lyall
    Gareth Tudor-Williams
    Caroline Foster
    Clinical Drug Investigation, 2019, 39 : 585 - 590
  • [37] Clinical efficacy and safety of certolizumab pegol in cutaneous symptoms on psoriasis in patients with psoriatic arthritis: A retrospective analysis in real life
    Dattola, Annunziata
    Mazzeo, Mauro
    Di Stefano, Flavia
    Manfreda, Valeria
    Vollono, Laura
    Di Raimondo, Cosimo
    Di Matteo, Eleonora
    Bianchi, Luca
    DERMATOLOGIC THERAPY, 2020, 33 (03)
  • [38] Clostridioides difficile infections caused by hypervirulent strains: a single-centre real-life study
    Tiecco, Giorgio
    De Francesco, Maria Antonia
    Lenzi, Angelica
    Pellizzeri, Simone
    Rossini, Francesco
    Sollima, Alessio
    Signorini, Liana
    Castelli, Francesco
    Caruso, Arnaldo
    Quiros-Roldan, Eugenia
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2025, 44 (01) : 99 - 107
  • [39] Clinical decision support tool for vedolizumab could not predict outcome in ulcerative colitis patients - a retrospective real-life single-centre cohort study
    Molinari, N.
    Macek, P.
    Ocepek, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1844 - I1844
  • [40] Efficacy and safety of tocilizumab in a real-life observational cohort of patients with polyarticular juvenile idiopathic arthritis
    Gronlund, Minna-Maija
    Remes-Pakarinen, Terhi
    Kroger, Liisa
    Markula-Patjas, Kati
    Backstrom, Maria
    Putto-Laurila, Anne
    Aalto, Kristiina
    Vahasalo, Paula
    RHEUMATOLOGY, 2020, 59 (04) : 732 - 741